SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001564590-21-027021
Filing Date
2021-05-12
Accepted
2021-05-12 16:21:41
Documents
10

Document Format Files

Seq Description Document Type Size
1 DEFR14A acad-defr14a_20210622.htm DEFR14A 2579953
2 GRAPHIC ghlxznapjdgw000071.jpg GRAPHIC 544247
3 GRAPHIC ghlxznapjdgw000069.jpg GRAPHIC 13811
4 GRAPHIC ghlxznapjdgw000023.jpg GRAPHIC 214604
5 GRAPHIC ghlxznapjdgw000002.jpg GRAPHIC 11677
6 GRAPHIC ghlxznapjdgw000037.jpg GRAPHIC 241762
7 GRAPHIC ghlxznapjdgw000072.jpg GRAPHIC 409225
8 GRAPHIC ghlxznapjdgw000001.jpg GRAPHIC 5236
9 GRAPHIC ghlxznapjdgw000024.jpg GRAPHIC 57061
10 GRAPHIC ghlxznapjdgw000026.jpg GRAPHIC 158434
  Complete submission text file 0001564590-21-027021.txt   4860010
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFR14A | Act: 34 | File No.: 000-50768 | Film No.: 21915432
SIC: 2834 Pharmaceutical Preparations